Q2 2024 Revenue Increased 11% to $49.9 Million ENGLEWOOD, Colo., July 25, 2024 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Acute kidney injury (AKI) and sepsis-induced acute kidney injury (S-AKI) are life-threatening conditions, with many patients dying and others left with long-term kidney damage requiring lifelong dialysis and resulting in early death. Terumo Blood and […]
Graybug Vision is in search of a new home about 21 months after landing on the Nasdaq. The ocular disease-focused biotech has seen its stock $GRAY plummet amid the biotech bear market, nosediving from a […]
The growth follows over $3 billion in new contracts to produce highly popular weight loss drugs. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Copyright © 2026 Biotech Networks
